Device Trial Radar · NCT04310150
Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial
Last checked: Nov 20, 2026Latest source record: Mar 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
Feb 5, 2018
Primary completion
Mar 17, 2020
Study completion Mar 31, 2020
Sponsor
- Lead sponsor
- Yonsei UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 19 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this prospective open-label randomized trial, 160 patients with elective off-pump coronary artery bypass (OPCAB) surgery were enrolled. After primary suture of aortocoronary anastomosis, if an area of hemorrhage was identified, patients were randomized to receive Floseal® or Collastat® (n=80), respectively. The selected agent was applied with compression of the target area for 1 min. If hemostasis was not achieved, the agent was re-applied for a further 1 min, and was repeated up to 5 min, after which rescue treatment was applied, including any conventional surgical methods.
Conditions
- Coronary Artery Disease
Interventions
CollastatDrug
hemostatic agent that combine porcine-derived collagen thrombin
FlosealDevice
hemostatic agent that combine bovine-derived gelatin
Primary outcomes
What the sponsor says the trial is designed to measure.
- the proportion of patients with complete hemostasisTime frame: Participants will be followed for the time required for hemostasis, an expected average of 3 minutes.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Severance Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.